Ken Arimura
-
- Lung Cancer Diagnosis and Treatment 5
- Tracheal and airway disorders 4
- Neonatal Respiratory Health Research 4
- Occupational and environmental lung diseases 3
- Lung Cancer Treatments and Mutations 3
- Medical Imaging and Pathology Studies 3
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
Ken Arimura
31 papers receiving 193 citations
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 128
- Physiology 28
- Endocrine and Autonomic Systems 7
- Immunology 19
- Cancer Research 12
Countries citing papers authored by Ken Arimura
This map shows the geographic impact of Ken Arimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Arimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Arimura more than expected).
Fields of papers citing papers by Ken Arimura
This network shows the impact of papers produced by Ken Arimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Arimura. The network helps show where Ken Arimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ken Arimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 0 | |
| 13 | 2019 | 22 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 37 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 13 | |
| 18 | 2014 | 19 | |
| 19 | 2012 | 1 | |
| 20 | 2001 | 5 |
About Ken Arimura
Ken Arimura is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Emergency Medical Services, having authored 32 papers that have together received 194 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers), Tracheal and airway disorders (4 papers), Neonatal Respiratory Health Research (4 papers), Occupational and environmental lung diseases (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Medical Imaging and Pathology Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (128 citations), Physiology (28 citations) and Endocrine and Autonomic Systems (7 citations). Ken Arimura has collaborated with scholars based in Japan and United States. Frequent co-authors include Mitsuko Kondo, Etsuko Tagaya, Jun Tamaoki, Kiyoshi Takeyama, Akitoshi Sato, Masato Kanzaki, Hideki Katsura, Yoji Nagashima, Kenzo Hiroshima and Mizue Hasegawa. Their work appears in journals such as Japanese Journal of Clinical Oncology, BMC Cancer, Respiratory Research, European Respiratory Journal and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.